Product Introduction
Thiamidol ingrediens patented anti-pigmentum elaboratum est post plus quam decem annos investigationis. Hoc activum ingrediens innovationis notat punctum metae in investigationis in remotionem pigmenti maculae - effectus thiamidol iaculis et convertitur, sic effecti probati sunt efficax et tutus. Ante hanc investigationem, ingrediens activam quae tam presse operatur, fieri non potuit. quin immo, donec tunc tantum fieri potuit, inhibere distributionem per eg niacianamides et alias activos ingredientes. Sola niacianamide inhibitor tyrosinae humanae non est et solum melanin transmissionem intermittit.
Munus
Effectus albi Thiamidol valde significantes;
1. Inhibitio tyrosinasi humanae activitati: Thiamidol est unus ex vehementissimis inhibitoribus actionis tyrosinasi humanae notae, quae melanin formationem a fonte inhibere potest.
2. Tuta et mitis: Thiamidol cytotoxicitatem non habet, et est candida mixtura tuta et mitis. Thiamidol magnas utilitates habet in aliis medicamentis dealbatio.
3. Effectiveness: Thiamidol efficaciter emendare melasma mitem, moderatum et vehementem potest, atque etiam efficaciter emendare maculas et maculas pigmentationis aetatis.
Testimonium Analysis
| Product Name | Thiamidol | Specification | Company Standard |
| CASNec. | 1428450-95-6 | OPIFICIUM Date | 2024.7.20 |
| quantitas | 100KG | Analysis Date | 2024.7.27 |
| Batch No. | ES-240720 | Exitus Date | 2026.7.19 |
| M. pondus | 278.33 | Symbolum hypotheticum | C₁₈H₂₃NO₃S |
| Items | Specifications | Proventus | |
| Aspectus | Alba ut off-alba pulveris | Obsequitur | |
| Lepidium sativum | Retentionis tempus solutionis maioris partis exempli solutionis correspondet solutioni normae | Obsequitur | |
| Aqua contenta | ≤1.0% | 0.20% | |
| RELICTUM solvendo (GC) | Acetonitrile≤0.041% | ND | |
|
| Dichloromethane≤0.06% | ND | |
|
| Toluene≤0.089% | ND | |
|
| Heptane≤0.5% | 60ppm | |
|
| Ethanol≤0.5% | ND | |
|
| Ethyl acetate≤0.5% | 1319ppm | |
|
| Acidum aceticum acid≤0.5% | ND | |
| Substantia cognata (HPLC) | Una Impurity≤1.0% | 0.27% | |
|
| Totalis Impuritics≤2.0% | 0.44% | |
| Residere in Ignition | ≤0.5% | 0.04% | |
| Assay.HPLC. | 98.0%~102.0% | 98.5% | |
| Repono | Condite in vase aereo stricto, a luce protecti. | ||
| Vita fasciae | biennio rite conditum. | ||
| conclusio | Secundum quid. | ||
Inspectionem personas Yan Li Review personas：Vifen Zhang Authorised personas：LeiLiu
Detail Image
